D'Orazio & Associates’s Merck MRK Stock Holding History

D'Orazio & Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$520K	Sell	4,050 -195	-5%	-$22.8K	0.06%	127
2026 Q1	$511K	Buy	4,245 +502	+13%	+$58K	0.07%	117
2025 Q4	$394K	Buy	3,743 +1,260	+51%	+$118K	0.05%	146
2025 Q3	$208K	Sell	2,483 -246	-9%	-$20.3K	0.03%	253
2025 Q2	$216K	Sell	2,729 -2,216	-45%	-$176K	0.03%	241
2025 Q1	$444K	Buy	4,945 +1,033	+26%	+$96.4K	0.07%	105
2024 Q4	$389K	Sell	3,912 -575	-13%	-$59.3K	0.06%	114
2024 Q3	$510K	Sell	4,487 -151	-3%	-$17.9K	0.07%	90
2024 Q2	$574K	Buy	4,638 +209	+5%	+$26.9K	0.09%	82
2024 Q1	$584K	Buy	4,429 +85	+2%	+$10.5K	0.09%	73
2023 Q4	$474K	Buy	4,344 +285	+7%	+$29.6K	0.08%	77
2023 Q3	$418K	Sell	4,059 -432	-10%	-$46.6K	0.09%	75
2023 Q2	$518K	Buy	4,491 +547	+14%	+$62.1K	0.12%	63
2023 Q1	$420K	Sell	3,944 -107	-3%	-$11.6K	0.11%	69
2022 Q4	$449K	Buy	4,051 +531	+15%	+$54.3K	0.11%	71
2022 Q3	$303K	Sell	3,520 -53	-1%	-$4.73K	0.09%	89
2022 Q2	$326K	Buy	3,573 +833	+30%	+$73.8K	0.09%	84
2022 Q1	$225K	Buy	+2,740	New	+$216K	0.05%	91
2021 Q4	–	Sell	-2,161	Closed	-$162K	–	470
2021 Q3	$162K	Buy	2,161 +1,520	+237%	+$116K	0.04%	106
2021 Q2	$50K	Sell	641 -31	-5%	-$2.31K	0.01%	168
2021 Q1	$49K	Hold	672	–	–	0.01%	169
2020 Q4	$52K	Buy	672 +43	+7%	+$3.29K	0.02%	153
2020 Q3	$50K	Sell	629 -128	-17%	-$10K	0.02%	140
2020 Q2	$56K	Hold	757	–	–	0.02%	128
2020 Q1	$56K	Buy	757 +128	+20%	+$10.1K	0.03%	120
2019 Q4	$55K	Hold	629	–	–	0.02%	139
2019 Q3	$51K	Hold	629	–	–	0.02%	144
2019 Q2	$50K	Sell	629 -104	-14%	-$7.96K	0.01%	143
2019 Q1	$58K	Buy	733 +104	+17%	+$7.78K	0.02%	132
2018 Q4	$46K	Hold	629	–	–	0.02%	134
2018 Q3	$43K	Hold	629	–	–	0.02%	140
2018 Q2	$36K	Hold	629	–	–	0.01%	142
2018 Q1	$33K	Hold	629	–	–	0.01%	144
2017 Q4	$34K	Buy	629 +418	+198%	+$23.2K	0.01%	150
2017 Q3	$13K	Sell	211 -523	-71%	-$31.7K	﹤0.01%	187
2017 Q2	$45K	Buy	734 +523	+248%	+$31.8K	0.02%	131
2017 Q1	$13K	Hold	211	–	–	0.01%	206
2016 Q4	$12K	Buy	211 +1	+0.5%	+$59	﹤0.01%	189
2016 Q3	$12K	Sell	210 -1	-0.5%	-$58	﹤0.01%	191
2016 Q2	$12K	Buy	211 +1	+0.5%	+$53	﹤0.01%	195
2016 Q1	$10K	Hold	210	–	–	﹤0.01%	216
2015 Q4	$11K	Sell	210 -417	-67%	-$21K	0.01%	187
2015 Q3	$32K	Buy	627 +138	+28%	+$7.33K	0.02%	122
2015 Q2	$27K	Hold	489	–	–	0.02%	132
2015 Q1	$27K	Hold	489	–	–	0.02%	135
2014 Q4	$26K	Hold	489	–	–	0.02%	127
2014 Q3	$28K	Hold	489	–	–	0.02%	125
2014 Q2	$27K	Hold	489	–	–	0.02%	130
2014 Q1	$26K	Hold	489	–	–	0.02%	126
2013 Q4	$23K	Buy	+489	New	+$22.4K	0.02%	117

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

D'Orazio & Associates's MRK Position: Q2 2026 in Review

D'Orazio & Associates reduced its Merck (MRK) stake by 4.6% in Q2 2026, selling an estimated $22.8K and leaving 4,050 shares worth $520K. The position accounts for 0.06% of the portfolio, ranked #127.

D'Orazio & Associates first reported a position in MRK in Q4 2013 and has held it in 50 quarters since. The position peaked at $584K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

D'Orazio & Associates held 4,050 shares of Merck worth $520K as of Q2 2026.
D'Orazio & Associates sold 195 Merck shares in Q2 2026, an estimated $22.8K.
Merck made up 0.06% of D'Orazio & Associates's portfolio in Q2 2026, its #127 holding.
D'Orazio & Associates first reported a position in Merck in Q4 2013 and has held it in 50 quarters since.
D'Orazio & Associates's Merck position peaked at $584K in Q1 2024.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on D'Orazio & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.